Enzymatic degradation of endomorphins

Peptides
Anna JaneckaJakub Fichna

Abstract

Centrally acting plant opiates, such as morphine, are the most frequently used analgesics for the relief of severe pain, even though their undesired side effects are serious limitation to their usefulness. The search for new therapeutics that could replace morphine has been mainly focused on the development of peptide analogs or peptidomimetics with high selectivity for one receptor type and high bioavailability, that is good blood-brain barrier permeability and enzymatic stability. Drugs, in order to be effective, must be able to reach the target tissue and to remain metabolically stable to produce the desired effects. The study of naturally occurring peptides provides a rational and powerful approach in the design of peptide therapeutics. Endogenous opioid peptides, endomorphin-1 and endomorphin-2, are two potent and highly selective mu-opioid receptor agonists, discovered only a decade ago, which display potent analgesic activity. However, extensive studies on the possible use of endomorphins as analgesics instead of morphine met with failure due to their instability. This review deals with the recent investigations that allowed determine degradation pathways of endomorphins in vitro and in vivo and propose modifications tha...Continue Reading

References

Jun 1, 1991·European Journal of Biochemistry·H T Harbeck, R Mentlein
May 7, 1987·European Journal of Pharmacology·M HachisuH Umezawa
Sep 1, 1984·The Journal of Antibiotics·H UmezawaT Takeuchi
Oct 20, 1995·Archives of Biochemistry and Biophysics·J LiS Wilk
Jan 1, 1995·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·A Sedo, R P Revoltella
Jan 1, 1995·Methods in Enzymology·K Takahashi
Jan 1, 1994·Methods in Enzymology·S J Remington, K Breddam
Jan 1, 1996·Nucleic Acids Research·A Bairoch
Jan 20, 1998·Biochimica Et Biophysica Acta·D F Cunningham, B O'Connor
Oct 24, 1998·Biochemical and Biophysical Research Communications·M SpeteaA Borsodi
Nov 13, 1998·Journal of Pharmaceutical Sciences·R D EgletonT P Davis
Mar 17, 1999·European Journal of Pharmacology·B PrzewłockaR Przewłocki
Jul 23, 1999·Brain Research·Y Q WangD F Cui
Jan 5, 2000·Life Sciences·G HorvathG Benedek
Jan 6, 2000·Japanese Journal of Pharmacology·A Sugimoto-WatanabeK Saito
Feb 2, 2000·Biophysical Journal·M G PaterliniP S Portoghese
Mar 4, 2000·Peptides·A L VaccarinoA J Kastin
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·M A CzaplaJ E Zadina
Jan 2, 2001·Bioorganic & Medicinal Chemistry Letters·G CardilloS Spampinato
Jun 9, 2001·Biochemical and Biophysical Research Communications·I SzatmáriI Lengyel
Sep 10, 2002·Peptides·Csaba TömbölyGéza Tóth
Jun 5, 2003·European Journal of Pharmacology·Santi SpampinatoGiuliana Cardillo
Sep 7, 2005·Bioorganic & Medicinal Chemistry·Rafal KruszynskiAnna Janecka
Sep 13, 2005·Behavioural Brain Research·Regis GuieuDidier Marguet
Apr 1, 1981·Plant Physiology·G M HassJ E Derr-Makus
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jakub FichnaJean-Claude do Rego

❮ Previous
Next ❯

Citations

Jun 12, 2012·Journal of Medicinal Chemistry·Pegah VaraminiIstvan Toth
Aug 25, 2011·Perspectives in Medicinal Chemistry·Joel S Goldberg
Apr 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Marlène PernotMuriel Barberi-Heyob
Dec 10, 2009·Peptides·Renata PerlikowskaAnna Janecka
May 14, 2009·Bioorganic & Medicinal Chemistry·Renata PerlikowskaAnna Janecka
May 22, 2010·ChemMedChem·Attila KeresztesGéza Tóth
Apr 20, 2010·Annals of the New York Academy of Sciences·David S JessopRainer H Straub
Oct 31, 2009·Basic & Clinical Pharmacology & Toxicology·Renata PerlikowskaAnna Janecka
Apr 4, 2015·Gut Microbes·Maria De AngelisMarco Gobbetti
Jul 7, 2015·Archives of Medical Research·Alexandra BocsikMária Wollemann
Oct 2, 2012·Bioorganic & Medicinal Chemistry·Pegah VaraminiIstvan Toth
May 3, 2014·Journal of Child Neurology·Salvador Marí-BausetMaría Morales-Suárez-Varela
Sep 7, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Magdalena Mizerska-Dudka, Martyna Kandefer-Szerszeń
Mar 8, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Justyna Piekielna-CiesielskaAnna Janecka
Feb 13, 2019·Journal of Pediatric Gastroenterology and Nutrition·Carlo AlessandriaFederico Balzola
Jul 12, 2019·World Journal of Hepatology·Daniela CampionCarlo Alessandria
Jun 25, 2019·Journal of Pediatric Gastroenterology and Nutrition·Carlo AlessandriaFederico Balzola
Dec 23, 2020·Problemy e̊ndokrinologii·Sergey V Gein, Tatyana A Baeva
May 26, 2015·ACS Medicinal Chemistry Letters·Justyna PiekielnaAnna Janecka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.